Skip to main content
. Author manuscript; available in PMC: 2019 Dec 19.
Published in final edited form as: JACC Cardiovasc Interv. 2016 Aug 22;9(16):1694–1702. doi: 10.1016/j.jcin.2016.05.039

FIGURE 2. Periprocedural Strategy in ROCKET AF.

FIGURE 2

Investigators were given discretion over how to manage study drug in the event of an invasive procedure, but were provided protocol guidance in the setting of elective versus urgent versus emergent procedure for study drug management. For urgent and emergent procedures, immediate cessation of study drug was necessary with monitoring and administration of therapeutic agents if the situation warranted.